Myriad Genetics, Inc.MYGNNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.12% | -3.12% | +0.76% | -3.56% | -0.38% |
| Gross Profit Growth | +11.78% | -2.47% | +3.20% | -4.01% | -2.72% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +5.81% | +1.67% | +2.10% | +2.42% | +2.41% |
| Weighted Average Shares Diluted Growth | +5.81% | +1.67% | +2.10% | +2.42% | +2.41% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -623.08% | +2914.29% | +60.61% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +1414.29% |
| Receivables Growth | +6.04% | +1.95% | +16.30% | -6.13% | -4.87% |
| Inventory Growth | +25.00% | +15.04% | +9.96% | +20.61% | +11.27% |
| Asset Growth | -10.37% | -9.40% | -37.58% | -32.66% | -31.24% |
| Book Value per Share Growth | -15.40% | -8.77% | -48.67% | -50.25% | -48.75% |
| Debt Growth | -7.76% | +7.36% | +7.89% | +48.36% | +49.54% |
| R&D Expense Growth | +53.33% | +10.44% | -5.54% | -1.05% | -20.81% |
| SG&A Expenses Growth | +317.18% | -3.49% | -4.28% | -0.14% | -8.60% |